Soluble interleukin-2 receptor is involved during systemic mycosis.
Chumpitazi
B F
BF
Lebeau
B
B
Legeais
C
C
Peyron
F
F
Picot
S
S
Ambroise-Thomas
P
P
Grillot
R
R
D000328:Adult; D000368:Aged; D001228:Aspergillosis / Q000209:etiology / Q000276:immunology; D002177:Candidiasis / Q000209:etiology / Q000276:immunology; D003453:Cryptococcosis / Q000209:etiology / Q000276:immunology; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000209:etiology / Q000276:immunology*; D015375:Receptors, Interleukin-2 / Q000032:analysis*; D012189:Retrospective Studies; D012995:Solubility
D015375:Receptors, Interleukin-2